# Docusign, Inc.: financial statements, quarterly

DOCU · Nasdaq · CIK 1261333 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/docu.md) · [Financials](/companies/docu/financials.md) · [Filings](/companies/docu/filings.md) · [Insiders](/companies/docu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/docu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [700](/filings/0001261333-24-000151.md) | [712 d](/filings/0001261333-26-000021.md) | [710](/filings/0001261333-25-000075.md) | [736](/filings/0001261333-25-000132.md) | [755](/filings/0001261333-25-000150.md) | [776 d](/filings/0001261333-26-000021.md) | [764](/filings/0001261333-26-000074.md) | [801](/filings/0001261333-26-000099.md) | [818](/filings/0001261333-25-000150.md) | [837 d](/filings/0001261333-26-000021.md) | [830](/filings/0001261333-26-000074.md) | [876](/filings/0001261333-26-000099.md) |
| Cost of revenue | $m | [143](/filings/0001261333-24-000151.md) | [148 d](/filings/0001261333-26-000021.md) | [149](/filings/0001261333-25-000075.md) | [155](/filings/0001261333-25-000132.md) | [157](/filings/0001261333-25-000150.md) | [160 d](/filings/0001261333-26-000021.md) | [157](/filings/0001261333-26-000074.md) | [165](/filings/0001261333-26-000099.md) | [171](/filings/0001261333-25-000150.md) | [170 d](/filings/0001261333-26-000021.md) | [171](/filings/0001261333-26-000074.md) | [178](/filings/0001261333-26-000099.md) |
| Gross profit | $m | [558](/filings/0001261333-24-000151.md) | [564 d](/filings/0001261333-26-000021.md) | [560](/filings/0001261333-25-000075.md) | [581](/filings/0001261333-25-000132.md) | [598](/filings/0001261333-25-000150.md) | [616 d](/filings/0001261333-26-000021.md) | [606](/filings/0001261333-26-000074.md) | [635](/filings/0001261333-26-000099.md) | [648](/filings/0001261333-25-000150.md) | [667 d](/filings/0001261333-26-000021.md) | [659](/filings/0001261333-26-000074.md) | [698](/filings/0001261333-26-000099.md) |
| Research and development | $m | [137](/filings/0001261333-24-000151.md) | [152 d](/filings/0001261333-26-000021.md) | [134](/filings/0001261333-25-000075.md) | [148](/filings/0001261333-25-000132.md) | [151](/filings/0001261333-25-000150.md) | [155 d](/filings/0001261333-26-000021.md) | [159](/filings/0001261333-26-000074.md) | [170](/filings/0001261333-26-000099.md) | [168](/filings/0001261333-25-000150.md) | [168 d](/filings/0001261333-26-000021.md) | [160](/filings/0001261333-26-000074.md) | [164](/filings/0001261333-26-000099.md) |
| Operating income | $m | [19.7](/filings/0001261333-24-000151.md) | [9.9 d](/filings/0001261333-26-000021.md) | [22.6](/filings/0001261333-25-000075.md) | [57.8](/filings/0001261333-25-000132.md) | [59.0](/filings/0001261333-25-000150.md) | [60.5 d](/filings/0001261333-26-000021.md) | [60.3](/filings/0001261333-26-000074.md) | [65.2](/filings/0001261333-26-000099.md) | [85.4](/filings/0001261333-25-000150.md) | [87.7 d](/filings/0001261333-26-000021.md) | [111](/filings/0001261333-26-000074.md) | [118](/filings/0001261333-26-000099.md) |
| Interest expense | $m | [1.6](/filings/0001261333-23-000103.md) | [1.7 d](/filings/0001261333-24-000045.md) | [0.1](/filings/0001261333-24-000087.md) | [0.5](/filings/0001261333-25-000132.md) | [0.5](/filings/0001261333-25-000150.md) | [0.4 d](/filings/0001261333-26-000021.md) | [0.5](/filings/0001261333-26-000074.md) | [0.8](/filings/0001261333-26-000099.md) | [0.7](/filings/0001261333-25-000150.md) | [0.6 d](/filings/0001261333-26-000021.md) | [0.6](/filings/0001261333-26-000074.md) | [0.6](/filings/0001261333-26-000099.md) |
| Income tax | $m | [(3.0)](/filings/0001261333-24-000151.md) | [2.5 d](/filings/0001261333-26-000021.md) | [2.8](/filings/0001261333-25-000075.md) | [(816)](/filings/0001261333-25-000132.md) | [9.2](/filings/0001261333-25-000150.md) | [(15.6) d](/filings/0001261333-26-000021.md) | [1.7](/filings/0001261333-26-000074.md) | [13.5](/filings/0001261333-26-000099.md) | [11.8](/filings/0001261333-25-000150.md) | [11.2 d](/filings/0001261333-26-000021.md) | [39.6](/filings/0001261333-26-000074.md) | [47.3](/filings/0001261333-26-000099.md) |
| Net income | $m | [38.8](/filings/0001261333-24-000151.md) | [27.2 d](/filings/0001261333-26-000021.md) | [33.8](/filings/0001261333-25-000075.md) | [888](/filings/0001261333-25-000132.md) | [62.4](/filings/0001261333-25-000150.md) | [83.5 d](/filings/0001261333-26-000021.md) | [72.1](/filings/0001261333-26-000074.md) | [63.0](/filings/0001261333-26-000099.md) | [83.7](/filings/0001261333-25-000150.md) | [90.3 d](/filings/0001261333-26-000021.md) | [78.2](/filings/0001261333-26-000074.md) | [77.7](/filings/0001261333-26-000099.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001261333-24-000151.md) | not reported | [0.16](/filings/0001261333-25-000075.md) | [4.26](/filings/0001261333-25-000132.md) | [0.30](/filings/0001261333-25-000150.md) | not reported | [0.34](/filings/0001261333-26-000074.md) | [0.30](/filings/0001261333-26-000099.md) | [0.40](/filings/0001261333-25-000150.md) | not reported | [0.40](/filings/0001261333-26-000074.md) | [0.40](/filings/0001261333-26-000099.md) |
| Basic EPS | $ per share | [0.19](/filings/0001261333-24-000151.md) | not reported | [0.16](/filings/0001261333-25-000075.md) | [4.34](/filings/0001261333-25-000132.md) | [0.31](/filings/0001261333-25-000150.md) | not reported | [0.35](/filings/0001261333-26-000074.md) | [0.31](/filings/0001261333-26-000099.md) | [0.41](/filings/0001261333-25-000150.md) | not reported | [0.40](/filings/0001261333-26-000074.md) | [0.41](/filings/0001261333-26-000099.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,189](/filings/0001261333-23-000103.md) | [797](/filings/0001261333-26-000021.md) | [817](/filings/0001261333-24-000087.md) | [619](/filings/0001261333-24-000121.md) | [611](/filings/0001261333-24-000151.md) | [649](/filings/0001261333-26-000021.md) | [657](/filings/0001261333-25-000075.md) | [600](/filings/0001261333-25-000132.md) | [583](/filings/0001261333-25-000150.md) | [602](/filings/0001261333-26-000099.md) | [548](/filings/0001261333-26-000074.md) | [528](/filings/0001261333-26-000099.md) |
| Current assets | $m | [2,043](/filings/0001261333-23-000103.md) | [1,568](/filings/0001261333-25-000024.md) | [1,490](/filings/0001261333-24-000087.md) | [1,343](/filings/0001261333-24-000121.md) | [1,332](/filings/0001261333-24-000151.md) | [1,489](/filings/0001261333-26-000021.md) | [1,377](/filings/0001261333-25-000075.md) | [1,319](/filings/0001261333-25-000132.md) | [1,307](/filings/0001261333-25-000150.md) | [1,491](/filings/0001261333-26-000099.md) | [1,256](/filings/0001261333-26-000074.md) | [1,269](/filings/0001261333-26-000099.md) |
| Total assets | $m | [3,338](/filings/0001261333-23-000103.md) | [2,971](/filings/0001261333-25-000024.md) | [2,927](/filings/0001261333-24-000087.md) | [3,754](/filings/0001261333-24-000121.md) | [3,770](/filings/0001261333-24-000151.md) | [4,013](/filings/0001261333-26-000021.md) | [3,947](/filings/0001261333-25-000075.md) | [3,950](/filings/0001261333-25-000132.md) | [3,982](/filings/0001261333-25-000150.md) | [4,230](/filings/0001261333-26-000099.md) | [3,984](/filings/0001261333-26-000074.md) | [3,961](/filings/0001261333-26-000099.md) |
| Current liabilities | $m | [2,189](/filings/0001261333-23-000103.md) | [1,661](/filings/0001261333-25-000024.md) | [1,605](/filings/0001261333-24-000087.md) | [1,607](/filings/0001261333-24-000121.md) | [1,599](/filings/0001261333-24-000151.md) | [1,832](/filings/0001261333-26-000021.md) | [1,741](/filings/0001261333-25-000075.md) | [1,776](/filings/0001261333-25-000132.md) | [1,784](/filings/0001261333-25-000150.md) | [2,039](/filings/0001261333-26-000099.md) | [1,889](/filings/0001261333-26-000074.md) | [1,973](/filings/0001261333-26-000099.md) |
| Total liabilities | $m | [2,373](/filings/0001261333-23-000103.md) | [1,842](/filings/0001261333-25-000024.md) | [1,790](/filings/0001261333-24-000087.md) | [1,793](/filings/0001261333-24-000121.md) | [1,781](/filings/0001261333-24-000151.md) | [2,010](/filings/0001261333-26-000021.md) | [1,933](/filings/0001261333-25-000075.md) | [1,962](/filings/0001261333-25-000132.md) | [2,001](/filings/0001261333-25-000150.md) | [2,312](/filings/0001261333-26-000099.md) | [2,164](/filings/0001261333-26-000074.md) | [2,242](/filings/0001261333-26-000099.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [965](/filings/0001261333-24-000151.md) | [1,130](/filings/0001261333-26-000021.md) | [1,137](/filings/0001261333-25-000132.md) | [1,961](/filings/0001261333-25-000150.md) | [1,989](/filings/0001261333-25-000150.md) | [2,003](/filings/0001261333-26-000099.md) | [2,015](/filings/0001261333-26-000099.md) | [1,988](/filings/0001261333-26-000099.md) | [1,982](/filings/0001261333-25-000150.md) | [1,918](/filings/0001261333-26-000099.md) | [1,820](/filings/0001261333-26-000099.md) | [1,719](/filings/0001261333-26-000099.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [264 d](/filings/0001261333-24-000151.md) | [271 d](/filings/0001261333-26-000021.md) | [255](/filings/0001261333-25-000075.md) | [220 d](/filings/0001261333-25-000132.md) | [234 d](/filings/0001261333-25-000150.md) | [308 d](/filings/0001261333-26-000021.md) | [251](/filings/0001261333-26-000074.md) | [246 d](/filings/0001261333-26-000099.md) | [290 d](/filings/0001261333-25-000150.md) | [377 d](/filings/0001261333-26-000021.md) | [322](/filings/0001261333-26-000074.md) | [335 d](/filings/0001261333-26-000099.md) |
| Capital expenditure | $m | [23.8 d](/filings/0001261333-24-000151.md) | [22.1 d](/filings/0001261333-26-000021.md) | [22.8](/filings/0001261333-25-000075.md) | [22.3 d](/filings/0001261333-25-000132.md) | [23.6 d](/filings/0001261333-25-000150.md) | [28.3 d](/filings/0001261333-26-000021.md) | [23.6](/filings/0001261333-26-000074.md) | [28.4 d](/filings/0001261333-26-000099.md) | [27.4 d](/filings/0001261333-25-000150.md) | [27.0 d](/filings/0001261333-26-000021.md) | [32.3](/filings/0001261333-26-000074.md) | [38.8 d](/filings/0001261333-26-000099.md) |
| Share repurchases | $m | [75.0 d](/filings/0001261333-24-000151.md) | [0.0 d](/filings/0001261333-26-000021.md) | [149](/filings/0001261333-25-000075.md) | [200 d](/filings/0001261333-25-000132.md) | [173 d](/filings/0001261333-25-000150.md) | [162 d](/filings/0001261333-26-000021.md) | [183](/filings/0001261333-26-000074.md) | [202 d](/filings/0001261333-26-000099.md) | [215 d](/filings/0001261333-25-000150.md) | [269 d](/filings/0001261333-26-000021.md) | [318](/filings/0001261333-26-000074.md) | [307 d](/filings/0001261333-26-000099.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [201](/filings/0001261333-23-000103.md) | [208](/filings/0001261333-24-000087.md) | [208](/filings/0001261333-24-000121.md) | [208](/filings/0001261333-24-000151.md) | [210](/filings/0001261333-25-000075.md) | [208](/filings/0001261333-25-000132.md) | [209](/filings/0001261333-25-000150.md) | [213](/filings/0001261333-26-000074.md) | [211](/filings/0001261333-26-000099.md) | [208](/filings/0001261333-25-000150.md) | [196](/filings/0001261333-26-000074.md) | [193](/filings/0001261333-26-000099.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 186,902,452 at 2026-08-31, from the cover of the [10-Q filed 2026-09-04](/filings/0001261333-26-000099.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.